文献速递糖尿病肥胖与代谢综合征

2型糖尿病而非胰岛素治疗与更晚期乳腺癌相关:全国癌症与药房登记联动研究

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries.
PubMed 文献 · Diabetes Care · 2019-01-24

该嵌套病例对照研究基于荷兰癌症登记-PHARMO数据库网络,纳入2002-2014年诊断的33377例乳腺癌女性,发现合并2型糖尿病者更常被诊断为更晚期肿瘤分期和更高组织学分级,但胰岛素(类似物)使用与乳腺癌特征无关联。

要点

  • 2型糖尿病与孕激素受体阴性乳腺癌风险降低相关(OR 0.77,95%CI 0.67-0.89)。
  • 胰岛素(类似物)使用与否与乳腺癌特征无显著差异。

核心结论

  • 合并2型糖尿病的女性较无糖尿病者更常被诊断为更具侵袭性的乳腺癌。
  • 未发现胰岛素(类似物)使用与更晚期乳腺癌肿瘤相关。

研究设计与样本

  • 嵌套病例对照研究,从荷兰癌症登记-PHARMO数据库网络选取2002-2014年诊断的乳腺癌女性33377例。
  • 2型糖尿病定义为乳腺癌诊断前接受至少2次非胰岛素降糖药配药,并与无糖尿病女性匹配。
  • 在2型糖尿病女性中比较胰岛素使用者与非使用者。

主要发现

  • 2型糖尿病女性较少出现孕激素受体阴性肿瘤(OR 0.77,95%CI 0.67-0.89)。
  • 其他乳腺癌特征(形态学、雌激素受体、HER2、分子亚型等)未见显著关联。
  • 2型糖尿病女性中胰岛素使用者(n=388)与非使用者(n=1179)的乳腺癌特征无差异。

临床怎么用

  • 对合并2型糖尿病的女性应关注乳腺癌筛查,警惕更晚期分期可能。
  • 胰岛素(类似物)使用本身不构成更晚期乳腺癌的风险信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether women with type 2 diabetes (T2D) develop a more advanced stage of breast cancer and whether treatment with insulin (analogs) is associated with specific breast cancer characteristics. RESEARCH DESIGN AND METHODS: For this nested case-control study, women with breast cancer diagnosed in 2002-2014 were selected from the linked Netherlands Cancer Registry-PHARMO Database Network (N = 33,377). T2D was defined as receiving two or more dispensings of noninsulin blood glucose-lowering drugs prior to breast cancer diagnosis. Women with T2D were matched to women without diabetes. Among women with T2D, insulin users and nonusers were compared. Multivariable ordinal logistic regression was used to investigate the association between T2D/insulin and breast cancer characteristics, including TNM classification (tumor size, lymph node status, metastasis), morphology, grade, estrogen receptor and progesterone receptor (PR), human epidermal growth factor receptor 2, and molecular subtype. RESULTS: Women with T2D (n = 1,567) were more often diagnosed with a more advanced tumor stage (odds ratio 1.28 [95% CI 13-1.44]) and a higher grade (1.22 [1.08-1.39]) though less often with a PR-negative breast tumor (0.77 [0.67-0.89]) than women without diabetes (n = 6,267). No associations were found for the other breast cancer characteristics. Women with T2D using insulin (n = 388) were not diagnosed with different breast cancer characteristics compared with women with T2D not using insulin (n = 1,179). CONCLUSIONS: Our study suggests that women with T2D are at increased risk to be diagnosed with a more aggressive type of breast cancer than women without diabetes. No evidence was found that the use of insulin (analogs) is associated with developing more advanced breast cancer tumors.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Overbeek JA, van Herk-Sukel MPP, Vissers PAJ, et al. Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries. Diabetes Care. 2019. PMID: 30679303. doi:10.2337/dc18-2146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。